AG真人官方

Health In Tech, Inc. (HIT) reporting person LinLin Qian, who serves as Chief Financial Officer, Director and a reported 10% owner, received a grant of 27,000 restricted shares of Class A Common Stock on 08/15/2025. The restricted shares were issued under the Health in Tech Equity Incentive Plan and vest based on operational milestones: 50% vest monthly over 12 months after the first specified program is launched and operational, and the remaining 50% vest monthly over 12 months after the second specified program is launched and operational. Following the transaction the reporting person beneficially owns 8,048,555 shares (which the filing states include 55,193 restricted shares and 7,993,362 Class A shares), while the filing excludes certain Class B shares and options.

Tim Johnson, the Chief Executive Officer, Director and 10% owner of Health In Tech, Inc. (HIT), was granted 34,000 restricted shares of Class A Common Stock on 08/15/2025. The shares were granted at $0 and are subject to performance-based vesting tied to the successful launch and full operation of two specified company programs: 50% vest monthly over 12 months after the first program is launched and operational, and the remaining 50% vest monthly over 12 months after the second program is launched and operational. After this grant the reporting person beneficially owns 22,469,741 shares, which the filing clarifies includes 62,193 restricted shares and 22,407,548 Class A shares and expressly excludes 9,000,000 Class B shares and 734,707 options to purchase Class A shares.

Health In Tech, Inc. (HIT) reporting person Imran Yousuf, Chief Technology Officer and Director, received a grant of 7,000 restricted Class A common shares on 08/15/2025. The restricted shares are subject to vesting tied to two separate product launches: 50% vests monthly over 12 months after the first specified program is successfully launched and operational, and the remaining 50% vests monthly over 12 months after the second specified program is successfully launched and operational. Following the grant the reporting person beneficially owns 107,000 shares (comprised of 100,000 shares and 7,000 restricted shares). The filing excludes 100,000 options to purchase Class A common stock.

Health In Tech insider Jonathan Del Lockett reported a grant of 7,000 restricted shares of Class A common stock on 08/15/2025. The restricted shares were granted under the Health in Tech Equity Incentive Plan and carry vesting conditions tied to the successful launch and full operation of two specified company programs: 50% of the restricted shares vest monthly over 12 months after the first program is launched, and the remaining 50% vest monthly over 12 months after the second program is launched. Following the reported transaction, Mr. Lockett beneficially owns 93,539 shares (including 22,105 restricted shares and 71,434 unrestricted Class A shares); the filing notes he also holds 165,085 options to purchase Class A common stock that are excluded from the ownership total.

Health In Tech, Inc. reported accelerating revenue and margin expansion for the six months ended June 30, 2025. Total revenues rose to $17.33 million from $10.13 million a year earlier, driven by higher fees and underwriting modeling services, producing gross profit of $11.67 million and net income of $1.13 million, up from $438,543. Cash and cash equivalents increased modestly to $8.14 million, supported in part by net IPO proceeds of $8.21 million received previously.

The balance sheet shows growth in non-current and other receivables to $3.85 million, reflecting purchases of deferred administrative surplus; accounts payable rose to $4.33 million. The company recognized a refund liability of $955,743 tied to a variable reconciliation clause with a carrier and recorded stock-based compensation expense of $1.20 million during the period. Significant customer and vendor concentrations and collection uncertainty on purchased receivables are material risks disclosed in the filing.